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The tuberculosis (TB) notiﬁ  cation rate is high and in-
creasing in 2 communities in Cape Town, South Africa. In 
2002, we conducted a prevalence survey among adults 
>15 years of age to determine the TB prevalence rate; 
15% of households in these communities were randomly 
sampled. All persons living in sampled households were 
eligible for chest radiography and sputum examination. Of 
the 3,483 adults who completed a questionnaire, 2,608 
underwent chest radiography and sputum examination. 
We detected 26 bacteriologically conﬁ  rmed TB cases and 
a prevalence of 10.0/1,000 (95% conﬁ  dence interval [CI] 
6.2–13.8 per 1,000). We found 18 patients with smear-
positive TB, of whom 8 were new patients (3.1/1,000, 
95% CI 0.9–5.1/1,000). More than half of patients with 
smear-positive TB (10, 56%) had previously been treated. 
Such patients may contribute to transmission of Myco-
bacterium tuberculosis and the high TB prevalence rate. 
Successful treatment of TB patients must be a priority.
I
n 2003, South Africa had an estimated incidence of 218 
new smear-positive tuberculosis (TB) cases per 100,000 
population. This country ranked eighth in the world for to-
tal number of TB cases per country and tenth for incidence 
rates (1). Western Cape Province had the highest notiﬁ  ca-
tion rate in this country (2). In Cape Town, the largest city 
in this province, the notiﬁ  cation rate for new smear-positive 
TB was 266/100,000 in 2002 (3). In Ravensmead and Uit-
sig, 2 neighboring urban communities in Cape Town, the 
rate of registered new smear-positive TB cases increased 
from 228/100,000 in 1994 to 299/100,000 in 1998 and to 
341/100,000 in 2002 (4,5).
Although improved case detection may account for 
these increases, a true increase in incidence may also be 
occurring. Currently, there is no reliable estimate of the 
TB situation in this region. Furthermore, no data are avail-
able on number of undetected cases in the 2 communities, 
care-seeking behavior and delay in diagnosis, and number 
of persons who previously had TB, all of which are fac-
tors that may contribute to transmission of TB. We suspect 
that this population contains a substantial number of TB pa-
tients who previously had this disease, and that this group 
contributes to transmission of TB and the persistent high 
rates of TB notiﬁ  cation.
The aim of this TB prevalence survey was to obtain 
a reliable estimate of the situation, and to determine the 
number of undetected cases in the 2 communities, the 
number of persons who have previously had TB, and the 
proportion of previously treated cases among undetected 
TB patients. Results of this study will be used to plan in-
terventions to control the TB epidemic in these 2 commu-
nities in Cape Town.
Methods
Study Area
We conducted a TB prevalence survey in the commu-
nities of Ravensmead and Uitsig, which have a total surface 
area of 3.5 km2. In 2001, the study area had a population 
of 36,334 (5). Two primary healthcare clinics and an adja-
cent tertiary care hospital serve the area. The World Health       
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Organization directly observed treatment short-course 
strategy was introduced in these 2 communities in 1997.
Study Design
The TB prevalence survey was part of a larger com-
munity survey, the Lung Health Survey. In addition to 
prevalence of TB, the Lung Health Survey aimed to deter-
mine the prevalence of lung diseases, including asthma and 
chronic obstructive pulmonary disease. The current report 
deals only with TB. Information on other lung diseases will 
be reported elsewhere.
The study included 2 neighborhoods with similar so-
cioeconomic status. We selected a random sample of all 
addresses in the study area and deﬁ  ned an address as the 
residential geographic location (either a physical street ad-
dress or the name and number of a ﬂ  at). A randomized 15% 
sample was taken from all residential addresses. A total of 
5,592 addresses were situated in the study area, of which 
839 households were selected for participation in the sur-
vey. The study protocol was reviewed and approved by the 
ethics committees of Stellenbosch University and the Uni-
versity of Cape Town.
Survey Procedures
The Lung Health Survey was conducted from July 1 
through December 15, 2002. Trained community workers 
counted the number of persons at each selected address. 
All persons at selected addresses (including the main house 
and all backyard shacks) were eligible for investigation. 
If the head of the household did not give consent for the 
household to be enrolled in the survey, the household was 
replaced with a household at an adjacent address, e.g., ﬁ  rst 
to the right and then to the left of the household that de-
clined participation. All persons living at the address were 
informed of the purpose of the survey, and written in-
formed consent was obtained from each participant before 
enrollment. The Lung Health Survey included both adults 
and children, but here we report data in our survey only for 
adults >15 years of age.
All participants, supervised by a trained ﬁ  eld worker, 
completed a questionnaire containing questions on de-
mographic characteristics and earlier TB treatment. Pa-
tient category and treatment outcome of previous disease 
episode(s) were obtained from the local healthcare center.
Participants were then transported to a nearby facil-
ity where chest radiographs (35 × 43 cm postero-anterior 
view) were performed by using a 200-mA chest radiogra-
phy machine. Within 1 week, a pulmonologist screened the 
radiographs for abnormalities. Persons with abnormalities 
that required immediate investigation or treatment were re-
ferred to a local hospital. An accredited reader assessed all 
radiographs when the survey was ﬁ  nished by using a stan-
dardized classiﬁ  cation system developed for epidemiologic 
surveys (6). Abnormalities were classiﬁ  ed as being either 
consistent with TB or not related to TB. Parenchymal, 
pleural, and central structure abnormalities were consid-
ered consistent with TB. A second experienced reader then 
reread a stratiﬁ  ed sample of 31% of the radiographs. Kappa 
agreement between the 2 readers was 0.69 (95% conﬁ  dence 
interval [CI] 0.64–0.74) for abnormalities consistent with 
TB and 0.47 (95% CI 0.42–0.53) for whether the radio-
graphic result was normal (6). On the basis of these results, 
a second reader was deemed unnecessary.
Upon request, each participant provided a sputum spec-
imen at the health center where the chest radiograph was 
obtained by using the active cycle of breathing technique 
(7). Specimens were collected in a wide-mouthed plastic 
container with a secure screw-top lid. This container was 
then transported to the laboratory where it was processed 
within 3 days. A second specimen was obtained from per-
sons who had a positive smear, a positive culture, or both, 
before they were referred for treatment to a nearby clinic.
Laboratory Procedures
One smear and 1 culture were prepared from each 
sputum specimen. Smears were stained by using the Ziehl-
Nielsen technique with carbol fuchsin and methylene blue. 
The smears were scored by 1 reader according to the guide-
lines of the International Union Against Tuberculosis and 
Lung Disease (8). A smear result was considered positive 
if we observed >1 acid-fast bacillus per 100 oil-immer-
sion ﬁ  elds. This provision included scanty smears because 
these are considered indicative of true positivity (9). Spu-
tum samples were liqueﬁ  ed and decontaminated with 4% 
NaOH by using standard procedures (10). Samples were 
then centrifuged at 3,000 × g for 15 minutes. Concentrated 
decontaminated sputum sediment was resuspended in 2 mL 
phosphate buffer (68 mmol/L, pH 6.8) and placed on Löw-
enstein-Jensen slants. These slants were then incubated at 
37°C for 6 weeks.
Deﬁ  nitions, Data Processing, and Statistical Analysis
A bacteriologically conﬁ  rmed case of TB was deﬁ  ned 
as a person with either 2 positive smears or 2 positive cul-
tures, or 1 positive smear and 1 positive culture. Participants 
with 1 positive smear or 1 positive culture whose chest ra-
diographs showed TB-related abnormalities, or those with 
a positive sputum smear or culture results from specimens 
collected at the health center within 2 months after sputum 
collection in the prevalence survey, were also considered to 
have bacteriologically conﬁ  rmed TB.
Data were entered into a Microsoft (Redmond, WA, 
USA) Access database. Inconsistencies between the 2 en-
tries were checked against original data and errors were 
corrected. Statistical analysis was performed by using 
SPSS version 12.0.1 for Windows (SPSS Inc., Chicago, Tuberculosis, Cape Town, South Africa
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IL, USA) and STATA version 8.0 for Windows (11). 
Prevalence of TB was calculated by dividing the number 
of TB cases by the number of participants who attempted 
to provide a sputum specimen. Those who were unable to 
provide a sputum specimen were considered smear-nega-
tive and culture-negative. Results include crude prevalence 
rates and prevalence rates adjusted for the cluster sampling 
design. Households served as the primary sampling units 
and variation at this level was taken into account. 
We calculated prevalence after applying a correction 
factor for 100% collection coverage. Results were weight-
ed to adjust for unequal coverage in the different sex and 
age groups (15–34 and >35 years of age). Separate weight-
ing was applied to participants in the original and replace-
ment samples. We calculated the sampling weight as the 
product of (1/selection probability of a household) and 
(1/participation rate). The selection probability of a house-
hold was 0.15 because we randomly sampled 15% of the 
households. The participation rate varied by group sam-
pled; e.g., 68% of women 15–34 years of age in the original 
sample had a chest radiograph performed. Sampling weight 
was (1/0.15) × (1/0.68) = 9.8. CIs were calculated by using 
the normal approximation to the binomial distribution.
Results
Study Population and Coverage of Measurements
Initially, heads of 625 (74%) of 839 households con-
sented to participate in the study. We replaced 212 of 214 
households that refused participation; 2 households could 
not be replaced. Of 214 nonparticipating households, 
81 provided demographic details of persons living in the 
household. Occupants of these 81 households did not dif-
fer from the 212 households that were resampled with 
respect to sex (odds ratio [OR] 1.00, 95% CI 0.82–1.23) 
or age (t = 0.33, p = 0.74, by Student t test). In the ﬁ  nal 
sample, residents within 837 households included 3,971 
adults, of whom 3,483 (88%) consented and completed a 
questionnaire (Figure). Of these, 2,608 (75%) had a chest 
radiograph and attempted to provide a sputum specimen. 
Persons >35 years of age (78%) had a chest radiograph 
more often than persons <35 years of age (72%) (OR 1.41, 
95% CI 1.21–1.65). More women (78%) than men (71%) 
had a chest radiograph (OR 1.48, 95% CI 1.26–1.72). Of 
those who had a chest radiograph, 1,170 (45%) were able 
to provide a sputum specimen. Thirteen specimens were 
contaminated or inadequate for culture because of insuf-
ﬁ  cient volume.
Prevalence of TB
Of 2,608 participants with chest radiographs, 702 
(26.9%) had an abnormality on the radiograph (95% CI 
25.2%–28.6%). In 337 (12.9%) of these radiographs, abnor-
malities were consistent with TB (95% CI 11.6%–14.2%) 
(Table 1). Prevalence of TB-related abnormalities on chest 
radiographs increased with age (χ2 for linear trend 59.1, 
p<0.001) and were more often seen in men (16%) than in 
women (11%) (OR 1.48, 95% CI 1.16–1.89).
Twenty-nine participants had a positive smear or posi-
tive culture, of whom 3 did not fulﬁ  ll the deﬁ  nition of a 
bacteriologically conﬁ  rmed TB case; 2 had a scanty smear 
and 1 had a positive culture. The remaining 26 participants 
fulﬁ  lled the deﬁ  nition of bacteriologically conﬁ  rmed TB, 
giving a prevalence of 10.0/1,000 (95% CI 6.2–13.8/1,000) 
(Table 1). Of these 26 patients with bacteriologically con-
ﬁ  rmed TB, 16 (62%) were new patients (no previous treat-
ment), giving a prevalence of new bacteriologically con-
ﬁ  rmed TB cases of 6.1/1,000 (95% CI 3.1–9.1/1,000). Ten 
(56%) of the 18 smear-positive patients had been previously 
treated for TB. The prevalence of previously treated smear-
positive TB cases was 3.8/1,000 (95% CI 1.5–6.2/1,000). 
Only 8 (44%) smear-positive cases were new cases, and the 
prevalence of new smear-positive TB cases was 3.1/1,000 
(95% CI 0.9–5.1/1,000). 
Correction for the cluster sampling design and adjust-
ment for noncoverage had little effect on the prevalence 
estimates (Table 1). Three of the 26 patients with bacte-
riologically conﬁ  rmed TB were receiving anti-TB therapy 
at the time of the survey. Nineteen of the remaining 23 pa-
Figure. Sample selection of 3,483 adults, Cape Town, South Africa, 
for the study. RESEARCH
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tients with detected cases began treatment <6 months after 
these cases were detected in the survey. Of those patients, 
12 were cured, 1 completed treatment without conﬁ  rmed 
smear conversion, 2 interrupted treatment, 1 died, and 3 
had an unknown outcome.
History of TB
All 10 patients with bacteriologically conﬁ  rmed TB 
who had previously received treatment for TB were smear-
positive. Four of the 10 previously treated patients had been 
considered cured during their previous disease episodes, 
and 3 had interrupted treatment before completion. For 3 
previously treated smear-positive patients, no information 
was available on the outcome of their previous disease epi-
sode (Table 2). Four patients had been treated for TB on 
more than 1 occasion before their cases were detected in 
the survey. Also, 3 previously treated patients lived in the 
same household. Bacteria isolated from 1 of 7 previously 
treated TB patients who underwent drug sensitivity testing 
were resistant to isoniazid (Table 2).
A history of TB was reported by 338 (9.7%) of 3,483 
adults (95% CI 8.7%–10.7%) (Table 1). The prevalence 
of bacteriologically conﬁ  rmed TB was 29.9/1,000 (95% 
CI 11.4–47.7/1,000) in those who were previously treated 
for TB compared with 5.1/1,000 (95% CI 2.6–7.6/1,000) 
for persons who had never had TB (OR 5.96, 95% CI 
2.68–13.25). Participants reporting a history of TB were 
signiﬁ  cantly older (mean 41 years) than participants who 
had never had TB (mean 38 years) (t = 2.59, p = 0.01, by 
Student t test). A history of TB was more common in men 
(12%) than in women (8%) (OR 1.60, 95% CI 1.27–2.01).
Discussion
The prevalence of bacteriologically conﬁ  rmed  TB 
in our study was high, and the proportion of patients that 
had >1 previous episode of TB was substantial. These data 
support the hypothesis that previously treated cases form 
a large proportion of TB patients in the 2 communities. 
Therefore, persons with previously treated TB are likely to 
contribute to transmission of Mycobacterium tuberculosis, 
and may also be a factor in maintaining high prevalence 
rates of TB.
Low treatment success rates may partly explain the 
high proportion of previously treated cases. Treatment suc-
cess rates for new smear-positive cases were 78% in 2001 
and 80% in 2002 (4), which were lower than the 85% rec-
ommended by the World Health Organization (1). Low 
cure rates in TB patients may lead to reactivation of this 
disease and could also result in patients with chronic TB 
who excrete TB bacilli over an extended period. Howev-
er, recent studies using DNA ﬁ  ngerprinting showed that a 
large proportion of recurrent TB in our study area is caused 
by exogenous reinfection rather than reactivation (12,13). 
Approximately 10% of the survey population had previ-
ously had TB, as shown by responses to the question of 
whether persons had ever had TB and by TB-related abnor-
malities on chest radiographs. Previously treated persons 
had a much higher prevalence rate of TB than persons who 
had never had TB. Achieving high cure rates and prevent-
ing TB patients from infecting other people must therefore 
be considered the highest priority.
The high proportion of previously treated undetected 
cases suggests that case detection for previously treated 
cases is insufﬁ  cient. A case-detection rate of 118% was re-
ported for new smear-positive cases in South Africa (1), 
but no information on previously treated cases has been 
reported. Further research is needed to determine the case-
detection rate for previously treated patients.
Previously treated TB is associated with multidrug-re-
sistant TB and may be associated with extensively drug-
resistant TB. A survey on drug resistance conducted in 
1992–1993 in the Western Cape Province showed a rate 
of 8.6% acquired and 3.2% initial drug resistance in Cape 
Town (14). Recently, a study among hospitalized children 
(<13 years of age) showed an increase in isoniazid resis-
tance from 6.9% in 1994–1998 to 12.8% in 2003–2005 
Table 1. Prevalence estimates of tuberculosis (TB) in adults  15 years of age, Cape Town, South Africa* 
Characteristic
No. positive/ 
no. tested 
Crude prevalence 
estimate
Prevalence estimate corrected for 
simple random sampling at 
household level 
Weighted prevalence 
estimate, corrected for 
sampling and nonresponse 
History of TB (questionnaire)  338/3,483 9.7%  
(8.7%–10.7%) 
9.7%
(8.6%–10.8%) 
9.8%
(8.7%–10.9%) 
TB abnormalities on chest 
radiograph
337/2,608 12.9%  
(11.6%–14.2%) 
12.9%
(11.6%–14.3%) 
12.9%
(11.5%–14.3%) 
Total smear-confirmed TB  18/2,608 6.9
(3.7–10.1) 
6.9
(3.3–10.5) 
7.1
(3.3–10.8) 
New smear-confirmed TB  8/2,608 3.1
(0.9–5.2) 
3.1
(0.9–5.2) 
3.0
(0.9–5.1) 
Total bacteriologically 
confirmed TB 
26/2,608 10.0
(6.2–13.8) 
10.0
(5.7–14.3) 
10.2
(5.8–14.6) 
New bacteriologically  
confirmed TB 
16/2,608 6.1
(3.1–9.1) 
6.1
(3.0–9.3) 
6.2
(3.0–9.3) 
*Prevalence estimates are per 1,000 unless otherwise stated (percentage values). Values in parentheses are 95% confidence intervals.  Tuberculosis, Cape Town, South Africa
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(15,16). Drug-resistant TB is probably not the driving force 
behind the high prevalence of TB in the 2 study communi-
ties; however, it is likely to become an increasingly impor-
tant factor.
Similarly, an increasing prevalence of HIV may be 
partly responsible for the increasing notiﬁ  cation rates for 
TB, but does not adequately explain the high prevalence of 
TB in this study (17). HIV prevalence in the study area is 
not known and was not measured in this study. However, 
we believe that the prevalence rate for HIV in the study area 
is less than the rate of 12.4% in women attending public an-
tenatal clinics in Cape Town in 2002 (18). Approximately 
6% of patients with newly diagnosed TB in Ravensmead 
and Uitsig are HIV positive.
The high prevalence rates of TB in Ravensmead and 
Uitsig are reminiscent of similar observations in Inuit com-
munities in Greenland, Canada, and the United States. In 
the Inuit population, an average annual incidence of active 
TB of 1,310/100,000 was reported from 1967 through 1969 
(19). The highest rates of TB were reported in persons who 
had previously had TB (20), which was also observed in 
our study.
Our study was limited by a sample size that was insuf-
ﬁ  cient to give precise prevalence estimates for bacteriolog-
ically conﬁ  rmed and smear-positive TB. This resulted in 
wide CIs around the prevalence estimate (95% CI 1–6/1,000 
for conﬁ  rmed new smear-positive TB). Sampling bias due 
to resampling was minimized by replacing households that 
refused participation with generally similar neighboring 
households. For households that refused participation but 
provided some basic information on household members, 
no age or sex differences were found. For households that 
did not provide any information and refused participation, 
age or sex differences could not be tested. 
Participants who were unable to provide a sputum 
specimen were considered to be smear negative and cul-
ture negative. This approach may have resulted in low 
prevalence estimates because some cases could have been 
missed. Okutan et al. (21) reported positive smears in 61% 
and positive cultures in 31% of gastric lavage specimens 
obtained from patients with suspected TB who were unable 
to provide sputum specimens. However, because the partic-
ipants in our survey represented the entire population, not 
just those with suspected cases of TB, we anticipate that the 
proportion of missed cases will be considerably lower. The 
strength of our study was that sputum smear and culture 
was attempted for all participants. This differs from most 
surveys in which screening of symptoms, results of chest 
radiography, or both, are used as the basis for deciding 
which sputum specimen should be examined (22–27).
In conclusion, this prevalence survey supports the hy-
pothesis that the prevalence of TB is extremely high in the 
area studied. Because previously treated smear-positive 
TB patients constituted more than half of the patients with 
prevalent smear-positive cases, the survey also suggests 
that these cases contribute to transmission of M. tubercu-
losis. Successful treatment of TB cases must be a priority 
in South Africa.
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